Word

TOXSTA

Status

Registered

Status Code

700

Status Date

Tuesday, July 27, 2021

Serial Number

79291052

Registration Number

6430556

Registration Date

Tuesday, July 27, 2021

Mark Type

5000

Filing Date

Wednesday, June 3, 2020

Published for Opposition

Tuesday, May 11, 2021

Trademark Owner History

JETEMA CO., LTD. - Original Registrant

Classifications

5 Pharmaceutical agents affecting sensory organs; pharmaceutical preparations for treating cramps; pharmaceutical preparations for treating muscle; pharmaceutical preparations for treating cerebral palsy; pharmaceutical preparations for treating hyperhidrosis; pharmaceutical agents affecting metabolism; bacteria poisons; Pharmaceutical preparations for treating headache; anaesthetics; pharmaceutical preparations for use in the cosmetic field, namely, medicated cosmetics; pharmaceuticals containing botulinum toxin for medical use for use in the treatment of neurological disorders, muscle disorders, nerve disorders, headaches, wrinkles, sports injuries, spasms, tremors and pain; botulinum toxin for medical use for use in the treatment of neurological disorders, muscle disorders, nerve disorders, headaches, wrinkles, sports injuries, spasms, tremors and pain; pharmaceutical preparations for the treatment of urogenital organ disorders; Pharmaceutical preparations for urogenital organs; pharmaceutical preparations for plastic surgery; anti-inflammatory and antipyretic preparations; pharmaceutical agents affecting digestive organs; veterinary substances and preparations for house pets for injuries and pain, namely, pharmaceuticals containing botulinum toxin; Cardiovascular agents for medical purposes; pharmaceutical preparations for treating neurological disorders; pharmaceutical preparations in the nature of botulinum toxin, botulinum toxin-haemagglutin complex, botulinum toxin fragments and other derivatives used to treat neurological diseases; Ophthalmic preparations; allergy medications; Chemical preparations for pharmaceutical purposes, namely, for neurological disorders, muscle disorders, nerve disorders, headaches, wrinkles, sports injuries, spasms, tremors and pain; Pharmaceutical agents for epidermis; drugs for medical purposes, namely, pharmaceutical preparations for the treatment of neurological disorders, muscle disorders, nerve disorders, headaches, wrinkles, sports injuries, spasms, tremors and pain; pharmaceutical preparations for skincare in the nature of botulinum toxin, botulinum toxin-haemagglutin complex, botulinum toxin fragments and other derivatives for medical purposes; pharmaceutical preparations for skin care treatment in the nature of botulinum toxin, botulinum toxin-haemagglutin complex, botulinum toxin fragments and other derivatives for medical purposes; medicines for human purposes, namely, pharmaceutical preparations for the treatment of neurological disorders, muscle disorders, nerve disorders, headaches, wrinkles, sports injuries, spasms, tremors and pain; Pharmaceutical preparations for orthopedic purposes; pharmaceutical preparations for treating wrinkles; analgesic preparations; medicines for dental purposes; pharmaceutical preparations for treating pain; pharmaceutical preparation for skin care; medicated preparations for skin treatment; pharmaceutical preparations for respiratory organs; preparations for the treatment of burns; preparations for the treatment of scar

Color is not claimed as a feature of the mark.

Trademark Events

Oct 6, 2023

New Representative At Ib Received

Jan 1, 2022

Final Decision Transaction Processed By Ib

Dec 13, 2021

Final Disposition Notice Sent To Ib

Dec 13, 2021

Final Disposition Processed

Oct 27, 2021

Final Disposition Notice Created, To Be Sent To Ib

Jul 27, 2021

Registered-Principal Register

May 11, 2021

Notification Processed By Ib

May 11, 2021

Official Gazette Publication Confirmation E-Mailed

May 11, 2021

Published For Opposition

Apr 21, 2021

Notification Of Possible Opposition Sent To Ib

Apr 21, 2021

Notice Of Start Of Opposition Period Created, To Be Sent To Ib

Apr 21, 2021

Notification Of Notice Of Publication E-Mailed

Apr 2, 2021

Approved For Pub - Principal Register

Mar 31, 2021

Teas/Email Correspondence Entered

Mar 31, 2021

Correspondence Received In Law Office

Mar 31, 2021

Teas Response To Office Action Received

Jan 8, 2021

New Representative At Ib Received

Oct 19, 2020

Refusal Processed By Ib

Oct 1, 2020

Non-Final Action Mailed - Refusal Sent To Ib

Oct 1, 2020

Refusal Processed By Mpu

Sep 11, 2020

Non-Final Action (Ib Refusal) Prepared For Review

Sep 10, 2020

Non-Final Action Written

Sep 3, 2020

Assigned To Examiner

Aug 11, 2020

Application Filing Receipt Mailed

Aug 7, 2020

New Application Office Supplied Data Entered

Aug 6, 2020

Sn Assigned For Sect 66a Appl From Ib